2,424
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial

, , , , , , , & show all
Article: 1864908 | Received 17 Sep 2020, Accepted 12 Dec 2020, Published online: 31 Dec 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.